Chief Scientific Officer, RAGE Biotech
| Role | Organisation | Sources |
|---|---|---|
| Chief Scientific Officer | RAGE Biotech | SmartCompany, Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Stories naming Dr Chris Wraight. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech RAGE Biotech has raised a $29 million Series A, with IP Group Australia and Hostplus leading, to fund human trials of its lung disease therapy; new executives were appointed.
Also Startup Daily
Biotech incubator CUREator has awarded its first grants, totalling $17.4 million, to 23 early-stage medical startups including Phrenix and RAGE Biotech, aiming to ready them for commercial investment.